These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 23506610)

  • 1. Bosentan and antiretroviral therapy in an HIV/HBV/HCV coinfected Chinese patient with HIV-related pulmonary arterial hypertension.
    Dai HL; Lu YB; Guang XF; Xiao ZC; Zhang M; Zhang WH
    Chin Med J (Engl); 2013 Mar; 126(6):1197-8. PubMed ID: 23506610
    [No Abstract]   [Full Text] [Related]  

  • 2. Highly active antiretroviral therapy compared with HAART and bosentan in combination in patients with HIV-associated pulmonary hypertension.
    Barbaro G; Lucchini A; Pellicelli AM; Grisorio B; Giancaspro G; Barbarini G
    Heart; 2006 Aug; 92(8):1164-6. PubMed ID: 16844879
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term effects of bosentan in patients with HIV-associated pulmonary arterial hypertension.
    Degano B; Yaïci A; Le Pavec J; Savale L; Jaïs X; Camara B; Humbert M; Simonneau G; Sitbon O
    Eur Respir J; 2009 Jan; 33(1):92-8. PubMed ID: 18799506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PHS guidelines for management of occupational exposure to HBV, HCV and HIV: implementation for health care facilities.
    Preboth M
    Am Fam Physician; 2001 Nov; 64(9):1635. PubMed ID: 11730317
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of viral hepatitis on HIV infection.
    Rockstroh JK
    J Hepatol; 2006; 44(1 Suppl):S25-7. PubMed ID: 16338020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective evaluation of pulmonary, systemic and hepatic haemodynamics in HIV-HCV-coinfected patients before and after antiviral therapy with pegylated interferon and ribavirin.
    Reiberger T; Payer BA; Ferlitsch A; Sieghart W; Breitenecker F; Aichelburg MC; Schmied B; Rieger A; Trauner M; Peck-Radosavljevic M;
    Antivir Ther; 2012; 17(7):1327-34. PubMed ID: 22948263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiretroviral treatment change among HIV, hepatitis B virus and hepatitis C virus co-infected patients in the Australian HIV Observational Database.
    Petoumenos K; Ringland C;
    HIV Med; 2005 May; 6(3):155-63. PubMed ID: 15876281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curing HIV-associated pulmonary arterial hypertension.
    Tcherakian C; Rivaud E; Zucman D; Metivier AC; Couderc LJ
    Eur Respir J; 2012 Apr; 39(4):1045-6. PubMed ID: 22467729
    [No Abstract]   [Full Text] [Related]  

  • 9. Understanding the pathogenesis and management of hepatitis B/HIV and hepatitis B/hepatitis C virus coinfection.
    Cheruvu S; Marks K; Talal AH
    Clin Liver Dis; 2007 Nov; 11(4):917-43, ix-x. PubMed ID: 17981235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High rates of active hepatitis B and C co-infections in HIV-1 infected Cameroonian adults initiating antiretroviral therapy.
    Laurent C; Bourgeois A; Mpoudi-Ngolé E; Kouanfack C; Ciaffi L; Nkoué N; Mougnutou R; Calmy A; Koulla-Shiro S; Ducos J; Delaporte E
    HIV Med; 2010 Jan; 11(1):85-9. PubMed ID: 19659944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virological and clinical aspects of HBV-HCV coinfection in HIV positive patients.
    Filippini P; Coppola N; Pisapia R; Martini S; Marrocco C; Di Martino F; Sagnelli C; Filippini A; Sagnelli E
    J Med Virol; 2007 Nov; 79(11):1679-85. PubMed ID: 17854026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of hepatitis C virus (HCV) infection in patients coinfected with HIV in the HIV Outpatient Study (HOPS), 1999-2007.
    Vellozzi C; Buchacz K; Baker R; Spradling PR; Richardson J; Moorman A; Tedaldi E; Durham M; Ward J; Brooks JT;
    J Viral Hepat; 2011 May; 18(5):316-24. PubMed ID: 20367803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome and effects of oral bosentan therapy in Taiwanese patients with advanced idiopathic pulmonary arterial hypertension.
    Hsu HH; Chen JS; Chen RJ; Ko WJ; Kuo SW; Wu ET; Wu MH; Wang JK; Lee YC
    Respir Med; 2007 Jul; 101(7):1556-62. PubMed ID: 17223329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fosamprenavir treatment in a highly active antiretroviral therapy schedule induces a HCV-RNA decrease and a Th1 network boost in HIV/HCV-coinfected patients.
    Perrella A; Sbreglia C; D'Antonio A; Atripaldi L; Perrella O
    Clin Microbiol Infect; 2010 Jun; 16(6):676-8. PubMed ID: 19681945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic steatosis in patients coinfected with human immunodeficiency virus/hepatitis C virus: a meta-analysis of the risk factors.
    Machado MV; Oliveira AG; Cortez-Pinto H
    Hepatology; 2010 Jul; 52(1):71-8. PubMed ID: 20578130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virus.
    Boyd A; Lacombe K; Miailhes P; Gozlan J; Bonnard P; Molina JM; Lascoux-Combe C; Serfaty L; Gault E; Desvarieux M; Girard PM
    J Viral Hepat; 2010 Jan; 17(1):65-76. PubMed ID: 19682317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful bosentan and nonnucleoside reverse transcriptase inhibitor-based therapy in a patient with acquired immunodeficiency syndrome and pulmonary arterial hypertension.
    Hardy H; Backman ES; Farber HW
    Pharmacotherapy; 2010 Apr; 30(4):139e-44e. PubMed ID: 20334465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertension.
    Sitbon O; Gressin V; Speich R; Macdonald PS; Opravil M; Cooper DA; Fourme T; Humbert M; Delfraissy JF; Simonneau G
    Am J Respir Crit Care Med; 2004 Dec; 170(11):1212-7. PubMed ID: 15317666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reconstitution of hepatitis B virus (HBV)-specific T cell responses with treatment of human immunodeficiency virus/HBV coinfection.
    Lascar RM; Gilson RJ; Lopes AR; Bertoletti A; Maini MK
    J Infect Dis; 2003 Dec; 188(12):1815-9. PubMed ID: 14673759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of long-term suppression of hepatitis B virus DNA by tenofovir as rescue treatment in patients coinfected by HIV.
    Quiros-Roldan E; Calabresi A; Lapadula G; Tirelli V; Costarelli S; Cologni G; Zaltron S; Puoti M; Carosi G; Torti C
    Antivir Ther; 2008; 13(3):341-8. PubMed ID: 18572746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.